Price$24.71-0.82 (-3.23%)
01:30 PM07:45 PM
News · 26 weeks69-29%
2026-01-182026-07-12
Mix3090d
- Insider17(57%)
- Other5(17%)
- SEC Filings5(17%)
- Analyst2(7%)
- Earnings1(3%)
Latest news
25 items- PREnovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary CareCT-RevitL™ launches in the United States, built on a foundation of 150+ published studies on photobiomodulation (PBM) therapy Designed to deliver deeper, faster and more consistent therapeutic outcomes for animals DALLAS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven medical technology company, today announced the U.S. launch of CT-RevitL™, the next-generation veterinary PBM laser therapy system from its Companion Animal Health business. CT-RevitL delivers enhanced clinical performance, greater mobility and a more intuitive treatment experience for veterinary teams and their patients. Laser therapy is one of the fastest-growing modalities i
- ANALYSTBMO Capital Markets initiated coverage on Enovis Corporation with a new price targetBMO Capital Markets initiated coverage of Enovis Corporation with a rating of Outperform and set a new price target of $29.00
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Enovis CorporationSCHEDULE 13G/A - Enovis CORP (0001420800) (Subject)
- INSIDERDirector Ortiz Christine was granted 846 shares, increasing direct ownership by 3% to 25,857 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- SECSEC Form 11-K filed by Enovis Corporation11-K - Enovis CORP (0001420800) (Filer)
- INSIDERChief Administrative Officer Engert Oliver bought $20,920 worth of shares (1,000 units at $20.92), increasing direct ownership by 2% to 53,640 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERAmendment: Chief Administrative Officer Engert Oliver was granted 1,000 shares, increasing direct ownership by 2% to 52,640 units (SEC Form 4)4/A - Enovis CORP (0001420800) (Issuer)
- INSIDERChief Administrative Officer Engert Oliver bought $25,948 worth of shares (1,200 units at $21.62), increasing direct ownership by 2% to 51,840 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERChief Administrative Officer Engert Oliver bought $23,000 worth of shares (1,000 units at $23.00), increasing direct ownership by 2% to 50,640 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- PREnovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and TeensSpinamic combines the curve-correction efficacy of rigid bracing with the comfort and mobility of dynamic braces, offering an optimal balance of therapy and patient wearabilityAvailable in 10 off-the-shelf sizes with an adjustable three-point pressure system, the brace enables fitting, imaging, and adjustment in a single visitSpinamic is now available in the United States, with regulatory clearance being pursued across additional markets worldwide DALLAS, TX, June 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven medical technology company, today announced the launch of the DonJoy Spinamic® Hybrid Scoliosis Brace, to be distributed by its subsidiary, DJO,
- INSIDERChief Administrative Officer Engert Oliver bought $22,220 worth of shares (1,000 units at $22.22), increasing direct ownership by 2% to 49,640 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- SECSEC Form SD filed by Enovis CorporationSD - Enovis CORP (0001420800) (Filer)
- INSIDERDirector Shirley Brady was granted 9,346 shares, increasing direct ownership by 9% to 110,589 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Lalor Angela S was granted 9,346 shares, increasing direct ownership by 42% to 31,486 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Ortiz Christine was granted 9,346 shares, increasing direct ownership by 60% to 25,011 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Bodem Barbara W. was granted 9,346 shares, increasing direct ownership by 63% to 24,201 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Okala Philip was granted 9,346 shares, increasing direct ownership by 63% to 24,201 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Wienbar Sharon L was granted 9,346 shares, increasing direct ownership by 29% to 41,946 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Perfall A Clayton was granted 9,346 shares, increasing direct ownership by 21% to 54,190 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Vinnakota Rajiv was granted 9,346 shares, increasing direct ownership by 33% to 37,608 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Kelly Liam was granted 9,346 shares, increasing direct ownership by 48% to 28,950 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- SECSEC Form S-8 filed by Enovis CorporationS-8 - Enovis CORP (0001420800) (Filer)
- SECEnovis Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Enovis CORP (0001420800) (Filer)
- INSIDERSVP, Chief Financial Officer Berry Phillip Benjamin (Ben) covered exercise/tax liability with 7,774 shares, decreasing direct ownership by 5% to 150,822 units (SEC Form 4) to cover withholding tax4 - Enovis CORP (0001420800) (Issuer)
- INSIDERChief Executive Officer Mcdonald Damien covered exercise/tax liability with 12,634 shares, decreasing direct ownership by 5% to 234,042 units (SEC Form 4) (withholding tax)4 - Enovis CORP (0001420800) (Issuer)
ENOV FAQ
6 questionsWhat does Enovis Corporation do?
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular...Where does ENOV stock trade?
Enovis Corporation (ENOV) is listed on NYSE.What sector and industry is ENOV in?
Enovis Corporation operates in the Health Care sector, Industrial Specialties industry.What are analysts saying about ENOV?
Enovis Corporation has had 8 recent analyst actions on file. The most recent action was from BMO Capital Markets: Outperform with a $2900.00 price target on 2026-07-09. Recent price targets range from $2900.00 to $4100.00.What companies are similar to ENOV?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare ENOV side-by-side with any of them on Quantisnow.How can I track ENOV on Quantisnow?
Quantisnow aggregates Enovis Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ENOV to receive live email and push alerts on every new disclosure.